TGFB1 and neoplasm: Transforming growth factor (TGF)‐β signalling plays an important role at the early stage of EMT programme in HCC development and MMP9 is a key target of the tumour‐progressive TGF‐β signalling, which might be a potential target for HCC therapy.38